.png)
We get to know you
before we try to help you.
.png)
The
Pre-Patient
Approach
Ignite Passion
for Health
Empowered
by AI
Patient-Focused
Vertical
Establishing
Trust
.png)
Unveiling Our Solution: The Pre-Patient
Centric Strategy
Leveraging our innovative approach, we put patients' perspectives, requirements, and priorities at the forefront -- even before they have stepped into the realm of drug development. By focusing on proactive health education tailored to their unique needs, we underscore the role of clinical trials in driving better health outcomes.
Our Formula
for Breakthroughs
& Success
Award-Winning Expertise
Our team is renowned for their accomplishments in diverse fields, ranging from digital strategy to media and education. Their extensive, diverse project portfolio is a testament to our capabilities.
Understanding Diversity
We go beyond merely acknowledging differing perspectives. Our holistic approach embraces diversity in all its complexity, recognizing its pivotal role in shaping the healthcare ecosystem.
Creativity & Authenticity
We don't just execute tasks - we innovate. Our unique approach to representation in discovery integrates creativity with an authentic flair, making us stand out in the crowd.
Committed to Innovation
Our strategic approaches meld cutting-edge data technology with resourceful design to deliver unmatched solutions.
.png)
.png)
Our Toolbox: Integrated Services for Optimal Results
AI-powered patient education and engagement
Hyper-targeted recruitment
Decentralized clinical solutions
Patient retention strategies
WHY DECENTRALIZED CLINICAL TRIALS?
85%
85% of clinical trials fail to retain enough patients.
70%
70% of potential participants live more than 2 hours away from their nearest study center which limits recruitment and retention.
80%
Out of 40,000 clinical trials recruiting in the US, 80% were delayed due to recruitment challenges.
30%
Across all clinical trials the average drop-out rate is 30%, when more than 12,000 people.
.png)
75%
More than 75% responded that collecting all data on their own at home or having nurses come to their home for all study visits were appealing choices.
R'Kes Starling, Founder & CEO
When my Mom was diagnosed with an unusual lung condition, we started researching potential treatments. We discovered a trial available for her, but it was too far away for her to participate. Seeing my mother's disappointment was a pivotal moment for me. I was a high-potential executive in the healthcare sector for McKesson, responsible for over $300 million in business, and I was still unable to help her. Fortunately, she overcame her illness, which inspired me to create Reveles to ensure that underserved populations can be a part of finding cures for current and future generations.
HOW CAN WE PARTNER?
To learn more about how we can work together to drive equity in healthcare discovery.
.png)